Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01521741 · ClinicalTrials.gov registry record
Prospective Screening for Breast Cancer-related Lymphedema
A clinical trial of Lymphedema, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT01521741: Recruiting study of Lymphedema, sponsored by Massachusetts General Hospital.
NCT01521741 is a study of Lymphedema that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 10,000 participants, above the 9,006-participant average among 34 other Lymphedema trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01521741, a study of Lymphedema, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objectives of this study are twofold: 1) to detect and determine the level of symptoms, functional disability, and changes in quality of life that breast cancer patients experience from changes in their arms during and after treatment for breast cancer by collecting patient reported outcome measures, objective measurements, and clinical information in a prospectively maintained database and 2) to improve breast cancer-related lymphedema outcomes by early detection using objective measurements and symptoms assessments and assess these outcomes by maintaining the data in a database in order to contribute to the literature. The secondary aim of this study is to assess extracellular fluid content in the upper extremity, breast, and/or trunk of patients treated for breast cancer before, during, and after treatment in order to better understand the role of bioimpedance spectroscopy in lymphedema screening.
Primary Outcome
During and following treatment for breast cancer patients' experience a variety of changes in their upper extremities. The subject responses to the patient-reported outcome measures (BCLE-SEI questionnaire) obtained throughout their breast cancer treatment process will be analyzed in conjunction with arm volume measurements taken with both perometry and bioimpedance spectroscopy. This will allow for the correlation between quantifiable limb volume changes and subject documented changes in arm us
Conditions Studied
Interventions
- OTHER Breast Cancer-Related Lymphedema Screening
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2009-08 |
| Est. Completion | 2026-12 |
What NCT01521741 shows while recruiting
NCT01521741 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 9,006-participant average among 34 other Lymphedema trials with a reported enrollment target (11% higher).
The record links to 1 condition, with Lymphedema appearing as the primary indexed condition, and to 1 intervention - of which Breast Cancer-Related Lymphedema Screening is the first listed.
NCT01521741 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01521741 about?
NCT01521741 is a clinical study titled "Prospective Screening for Breast Cancer-related Lymphedema". The primary objectives of this study are twofold: 1) to detect and determine the level of symptoms, functional disability, and changes in quality of life that breast cancer patients experience from changes in their arms during and after treatment for breast cancer by collecting patient reported outc...
What is the current status of trial NCT01521741?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2009-08. Estimated completion is 2026-12.
What conditions does trial NCT01521741 study?
This clinical trial studies the following conditions: Lymphedema.
What interventions are being tested in trial NCT01521741?
The interventions under investigation include: Breast Cancer-Related Lymphedema Screening (OTHER).
Who is sponsoring clinical trial NCT01521741?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01521741 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01521741's enrollment target sits among peer trials
10,000 2nd of 34 the highest of 34 other Lymphedema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphedema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lymphedema Surveillance Study
RECRUITING
-
Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema
RECRUITING · Early Phase 1
-
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
RECRUITING · Phase 2
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
RECRUITING · Phase 3
-
Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia